Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for SHC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 665.65M
March 31, 2026 622.50M
December 31, 2025 606.04M
September 30, 2025 550.47M
June 30, 2025 511.28M
March 31, 2025 414.09M
December 31, 2024 404.91M
September 30, 2024 470.16M
June 30, 2024 422.76M
March 31, 2024 429.39M
December 31, 2023 443.73M
September 30, 2023 377.47M
June 30, 2023 418.37M
March 31, 2023 361.12M
Date Value
December 31, 2022 350.24M
September 30, 2022 606.73M
June 30, 2022 636.00M
March 31, 2022 642.13M
December 31, 2021 586.10M
September 30, 2021 525.77M
June 30, 2021 523.27M
March 31, 2021 463.26M
December 31, 2020 452.30M
September 30, 2020 -663.86M
June 30, 2020
March 31, 2020
December 31, 2019 -642.57M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Ginkgo Bioworks Holdings, Inc. 420.28M
Natera, Inc. 1.821B
Myriad Genetics, Inc. 303.90M
Guardant Health, Inc. -222.87M
Quest Diagnostics, Inc. 7.516B

Shareholders Equity (Quarterly) Related Metrics